IT1195304B
(it)
|
1981-12-22 |
1988-10-12 |
Anic Spa |
Metodo per la preparazione di gem-diammino derivati n-monoacilati
|
US4631211A
(en)
|
1985-03-25 |
1986-12-23 |
Scripps Clinic & Research Foundation |
Means for sequential solid phase organic synthesis and methods using the same
|
US4698327A
(en)
|
1985-04-25 |
1987-10-06 |
Eli Lilly And Company |
Novel glycopeptide derivatives
|
US4980286A
(en)
|
1985-07-05 |
1990-12-25 |
Whitehead Institute For Biomedical Research |
In vivo introduction and expression of foreign genetic material in epithelial cells
|
IT1190389B
(it)
|
1985-09-19 |
1988-02-16 |
Eniricerche Spa |
Esapeptidi ad attivita' ipotensiva
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
US5169933A
(en)
|
1988-08-15 |
1992-12-08 |
Neorx Corporation |
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
|
IT1227907B
(it)
|
1988-12-23 |
1991-05-14 |
Eniricerche S P A Milano Sclav |
Procedimento per la sintesi di peptidi retro-inversi e nuovi intermediin tale procedimento
|
WO1990007936A1
(en)
|
1989-01-23 |
1990-07-26 |
Chiron Corporation |
Recombinant therapies for infection and hyperproliferative disorders
|
GB8919607D0
(en)
|
1989-08-30 |
1989-10-11 |
Wellcome Found |
Novel entities for cancer therapy
|
US5652122A
(en)
|
1989-12-21 |
1997-07-29 |
Frankel; Alan |
Nucleic acids encoding and methods of making tat-derived transport polypeptides
|
US6316003B1
(en)
|
1989-12-21 |
2001-11-13 |
Whitehead Institute For Biomedical Research |
Tat-derived transport polypeptides
|
US5804604A
(en)
|
1989-12-21 |
1998-09-08 |
Biogen, Inc. |
Tat-derived transport polypeptides and fusion proteins
|
US5840313A
(en)
|
1990-09-27 |
1998-11-24 |
Syntello Vaccine Development Kb |
Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
|
WO1992018138A1
(en)
|
1991-04-10 |
1992-10-29 |
The General Hospital Corporation |
Mammalian gap-43 compositions and methods of use
|
US5350835A
(en)
|
1991-11-05 |
1994-09-27 |
Board Of Regents, University Of Texas |
Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids
|
US5994108A
(en)
|
1991-11-05 |
1999-11-30 |
Board Of Regents, The University Of Texas System |
Mutant TAR virus and transdominant tat mutants as pharmacological agents
|
CA2131620A1
(en)
|
1992-03-20 |
1993-09-30 |
Louis C. Smith |
A dna transporter system and method of use
|
ES2221920T3
(es)
|
1992-04-03 |
2005-01-16 |
The Regents Of The University Of California |
Sistema de liberacion de polinucleotidos de autoensamblaje que comprende un peptido cationico anfipatico.
|
WO1994004562A1
(en)
|
1992-08-13 |
1994-03-03 |
The General Hospital Corporation |
Mammalian gap-43 compositions and methods of use
|
CA2135642C
(en)
|
1992-08-21 |
1999-12-14 |
James G. Barsoum |
Tat-derived transport polypeptides
|
DE69333397T2
(de)
|
1992-08-27 |
2004-12-09 |
Bioclones (Proprietary) Ltd., Sandton |
Retro-, inverso-, und retro-inverso synthetische peptidanaloge
|
US5545551A
(en)
|
1992-08-28 |
1996-08-13 |
Mt. Sinai School Of Medicine Of The City University Of New York |
Cloning and expression of pur protein
|
AU689758B2
(en)
|
1992-10-09 |
1998-04-09 |
Advanced Tissue Sciences, Inc. |
Liver reserve cells
|
US5981568A
(en)
|
1993-01-28 |
1999-11-09 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
WO1994023751A1
(de)
|
1993-04-14 |
1994-10-27 |
Boehringer Mannheim Gmbh |
Nukleinsäure-transferpeptide und deren verwendung zur einschleusung von nukleinsäuren in eukaryontische zellen
|
WO1995014772A1
(fr)
|
1993-11-12 |
1995-06-01 |
Kenichi Matsubara |
Signature genique
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
US5807746A
(en)
|
1994-06-13 |
1998-09-15 |
Vanderbilt University |
Method for importing biologically active molecules into cells
|
CA2193354A1
(en)
|
1995-04-25 |
1996-10-31 |
Catherine Lee |
Composition containing collagenase and chymopapain for isolating hepatocytes and pancreatic islet cells
|
CA2227786A1
(en)
|
1995-07-28 |
1997-02-13 |
Marie Curie Cancer Care |
Transport proteins and their uses
|
WO1997010836A1
(en)
|
1995-09-21 |
1997-03-27 |
Innapharma, Inc. |
Peptides and peptidomimetics inhibiting the oncogenic action of p21 ras
|
IE80466B1
(en)
|
1995-11-10 |
1998-07-29 |
Elan Corp Plc |
Peptides which enhance transport across tissues and methods of identifying and using the same
|
US5877282A
(en)
|
1996-09-20 |
1999-03-02 |
Bristol-Myers Squibb Company |
Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
|
US6187817B1
(en)
|
1996-10-03 |
2001-02-13 |
Southern Illinois University School Of Medicine |
Therapeutic use of d-methionine to reduce the toxicity of platinum-containing anti-tumor compounds
|
US6361938B1
(en)
|
1996-11-08 |
2002-03-26 |
Elan Corporation, Plc |
Peptides which enhance transport across tissues and methods of identifying and using the same
|
AU7410998A
(en)
|
1996-11-26 |
1998-06-22 |
Johns Hopkins University, The |
Ligand detection system and methods of use thereof
|
US5989814A
(en)
|
1997-04-01 |
1999-11-23 |
Reagents Of The University Of California |
Screening methods in eucaryotic cells
|
US5880261A
(en)
|
1997-04-03 |
1999-03-09 |
Waeber; Gerard |
Transcription factor Islet-Brain 1 (IB1)
|
AU6972798A
(en)
|
1997-04-18 |
1998-11-13 |
University Of Medicine And Dentistry Of New Jersey |
Inhibition of hiv-1 replication by a tat rna-binding domain peptide analog
|
US6043083A
(en)
|
1997-04-28 |
2000-03-28 |
Davis; Roger J. |
Inhibitors of the JNK signal transduction pathway and methods of use
|
JP4129298B2
(ja)
|
1997-05-15 |
2008-08-06 |
サイトジェン コーポレーション |
胃腸管(git)輸送受容体に結合するランダムペプチド、及び関連した方法
|
US20040152084A1
(en)
|
2003-01-31 |
2004-08-05 |
Slattum Paul M. |
Compounds and processes for single-pot attachment of a label to nucleic acid
|
ES2210761T3
(es)
|
1997-05-21 |
2004-07-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Composicion y procedimiento para mejorar el transporte a traves de las membranas biologicas.
|
FR2767323B1
(fr)
|
1997-08-12 |
2001-01-05 |
Synt Em |
Peptides lineaires derives de peptides antibiotiques, leur preparation et leur utilisation pour vectoriser des substances actives
|
EP0897002A3
(en)
|
1997-08-14 |
2001-10-04 |
Smithkline Beecham Plc |
U62317, a protein having a JNK-binding domain
|
AU9402898A
(en)
|
1997-09-26 |
1999-04-23 |
Washington University |
Cell death agonists
|
US6420031B1
(en)
|
1997-11-03 |
2002-07-16 |
The Trustees Of Princeton University |
Highly transparent non-metallic cathodes
|
AU745579B2
(en)
|
1997-10-20 |
2002-03-21 |
F. Hoffmann-La Roche Ag |
Bicyclic kinase inhibitors
|
US6270956B1
(en)
|
1997-12-11 |
2001-08-07 |
The Salk Institute For Biological Studies |
Transcriptional coactivator that interacts with Tat protein and regulates its binding to TAR RNA, methods for modulating Tat transactivation, and uses therefor
|
EP0947524A1
(en)
|
1998-03-30 |
1999-10-06 |
Upither B.V. |
Novel peptides for the treatment of autoimmune diseases
|
US6248558B1
(en)
|
1998-03-31 |
2001-06-19 |
Vanderbilt University |
Sequence and method for genetic engineering of proteins with cell membrane translocating activity
|
CA2330458A1
(en)
|
1998-04-29 |
1999-11-04 |
Georgetown University |
Methods of identifying and using hla binding compounds as hla-agonists and antagonists
|
WO1999058692A2
(en)
|
1998-05-13 |
1999-11-18 |
Incyte Pharmaceuticals, Inc. |
Human apoptosis associated proteins
|
US6811992B1
(en)
|
1998-05-14 |
2004-11-02 |
Ya Fang Liu |
Method for identifying MLK inhibitors for the treatment of neurological conditions
|
WO1999058561A1
(fr)
|
1998-05-14 |
1999-11-18 |
Pasteur Merieux Serums & Vaccins |
Mimotopes du virus de l'hepatite c
|
WO1999066061A1
(fr)
|
1998-06-18 |
1999-12-23 |
Dnavec Research, Inc. |
Phage de transfert d'acide nucleique
|
US8038984B2
(en)
|
1998-06-20 |
2011-10-18 |
Washington University |
Membrane-permeant peptide complexes for treatment of sepsis
|
CA2328457A1
(en)
|
1998-06-20 |
1999-12-29 |
Washington University |
Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
|
US6589503B1
(en)
|
1998-06-20 |
2003-07-08 |
Washington University |
Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
|
ATE258946T1
(de)
|
1998-08-28 |
2004-02-15 |
Gryphon Sciences |
Verfahren zur herstellung von polyamidketten von genauer länge und deren konjugate mit proteinen
|
JP2002525329A
(ja)
|
1998-09-25 |
2002-08-13 |
セフアロン・インコーポレーテツド |
感覚毛細胞及び蝸牛ニューロンへの損傷を予防する/処置するための方法
|
US20020090696A1
(en)
|
1998-12-08 |
2002-07-11 |
Miller Carol A. |
Treating neurological disorders using human apoptosis inhibiting protein
|
US6656474B1
(en)
|
1999-01-15 |
2003-12-02 |
Regeneron Pharmaceuticals, Inc. |
Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders
|
US6673908B1
(en)
|
1999-02-22 |
2004-01-06 |
Nuvelo, Inc. |
Tumor necrosis factor receptor 2
|
JP2003506071A
(ja)
|
1999-05-28 |
2003-02-18 |
アポプトシス テクノロジー,アイエヌシー. |
アポトーシスを制御する化合物および方法ならびにアポトーシスを制御する化合物を製造およびスクリーニングする方法
|
US7510824B2
(en)
|
1999-06-02 |
2009-03-31 |
Nono Inc. |
Method of screening peptides useful in treating traumatic injury to the brain or spinal cord
|
AU5316900A
(en)
|
1999-06-03 |
2000-12-28 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-jun n-terminal kinases (jnk)
|
DK1102785T3
(da)
|
1999-06-07 |
2013-05-13 |
Arrowhead Res Corp |
Sammensætninger til lægemiddeltilførsel ved anvendelse af pH-følsomme molekyler
|
CA2381425A1
(en)
|
1999-08-24 |
2001-03-01 |
Cellgate, Inc. |
Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
|
US6669951B2
(en)
|
1999-08-24 |
2003-12-30 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
EP1210362A2
(en)
|
1999-09-01 |
2002-06-05 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses
|
US20030104622A1
(en)
|
1999-09-01 |
2003-06-05 |
Robbins Paul D. |
Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
|
US20040082509A1
(en)
|
1999-10-12 |
2004-04-29 |
Christophe Bonny |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
US8183339B1
(en)
|
1999-10-12 |
2012-05-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
US20030108539A1
(en)
|
2000-02-14 |
2003-06-12 |
Christophe Bonny |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
US6610820B1
(en)
|
1999-10-12 |
2003-08-26 |
University Of Lausanne |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
US20010046489A1
(en)
|
1999-12-06 |
2001-11-29 |
Habener Joel E. |
Stem cells of the islets of langerhans and their use in treating diabetes mellitus
|
EP1242118B1
(en)
|
1999-12-16 |
2009-11-11 |
Biogen Idec MA Inc. |
Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists
|
WO2001098324A1
(en)
|
2000-06-16 |
2001-12-27 |
Zealand Pharma A/S |
Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
|
US6586403B1
(en)
|
2000-07-20 |
2003-07-01 |
Salpep Biotechnology, Inc. |
Treating allergic reactions and inflammatory responses with tri-and dipeptides
|
US6897231B2
(en)
|
2000-07-31 |
2005-05-24 |
Signal Pharmaceuticals, Inc. |
Indazole derivatives as JNK inhibitors and compositions and methods related thereto
|
JP4387669B2
(ja)
|
2000-10-13 |
2009-12-16 |
ザイジェン エス.アー. |
新規なトランスポーターペプチド配列による生物学的エフェクターの細胞内送達
|
US7033597B2
(en)
|
2000-10-13 |
2006-04-25 |
Université de Lausanne |
Intracellular delivery of biological effectors
|
ES2386505T3
(es)
|
2000-10-17 |
2012-08-22 |
Diatranz Otsuka Limited |
Preparación y xenotrasplante de islotes de cerdo
|
US7199124B2
(en)
|
2001-02-02 |
2007-04-03 |
Takeda Pharmaceutical Company Limited |
JNK inhibitor
|
US20030077826A1
(en)
|
2001-02-02 |
2003-04-24 |
Lena Edelman |
Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)
|
WO2002062396A2
(en)
|
2001-02-08 |
2002-08-15 |
University Of Medicine And Dentistry Of New Jersey |
Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents using polymer conjugates
|
WO2002065986A2
(en)
|
2001-02-16 |
2002-08-29 |
Cellgate, Inc. |
Transporters comprising spaced arginine moieties
|
DE10117281A1
(de)
|
2001-04-06 |
2002-10-24 |
Inst Molekulare Biotechnologie |
Peptid zur Diagnose und Therapie der Alzheimer-Demenz
|
WO2002081504A2
(en)
|
2001-04-06 |
2002-10-17 |
Thomas Jefferson University |
Multimerization of hiv-1 vif protein as a therapeutic target
|
AU2002322519A1
(en)
|
2001-07-17 |
2003-03-03 |
Incyte Genomics, Inc. |
Proteins associated with cell growth, differentiation, and death
|
MXPA04002243A
(es)
|
2001-09-19 |
2004-06-29 |
Aventis Pharma Sa |
Compuestos quimicos.
|
GB0129044D0
(en)
|
2001-12-05 |
2002-01-23 |
Koninkl Philips Electronics Nv |
Data storage methods and apparatuses with basic and extended file system capacity
|
WO2003057725A2
(en)
|
2002-01-09 |
2003-07-17 |
University Of Lausanne |
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
|
EP1487436A4
(en)
|
2002-03-08 |
2009-06-03 |
Signal Pharm Inc |
POLYTHERAPY FOR TREATING, PREVENTING OR MANAGING PROLIFERATIVE DISORDERS AND CANCERS
|
SE0201863D0
(en)
|
2002-06-18 |
2002-06-18 |
Cepep Ab |
Cell penetrating peptides
|
JP2004066595A
(ja)
|
2002-08-05 |
2004-03-04 |
Canon Finetech Inc |
記録装置およびレジストレーション用パターンの記録方法
|
AU2003267124A1
(en)
|
2002-09-09 |
2004-03-29 |
Dana-Farber Cancer Institute, Inc. |
Bh3 peptides and method of use thereof
|
EP1542768A1
(en)
|
2002-09-20 |
2005-06-22 |
Alcon, Inc. |
Use of cytokine synthesis inhibitors for the treatment of dry eye disorders
|
PT1408114E
(pt)
|
2002-10-11 |
2007-04-30 |
Imvision Gmbh |
Moléculas modulares de transportes de antigénios ( moléculas mat ) para modulação de respostas imunitárias, correspondentes construções, processos e utilizações.
|
AU2003286611A1
(en)
*
|
2002-10-24 |
2004-05-13 |
Sangstat Medical Corporation |
Cytomodulating peptides and methods for treating neurological disorders
|
EP1578365A4
(en)
|
2002-11-14 |
2009-09-23 |
Arbor Vita Corp |
MOLECULAR INTERACTIONS IN NEURONS
|
RU2005118425A
(ru)
|
2002-11-15 |
2006-02-10 |
Сэнгстат Медикал Корпорейшн (Us) |
Цитомодуляторные пептиды для лечения интерстициального цистита
|
AU2003294312A1
(en)
|
2002-11-18 |
2004-07-09 |
Celgene Corporation |
Methods of usig and compositions comprising (-)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide
|
US20050019366A1
(en)
|
2002-12-31 |
2005-01-27 |
Zeldis Jerome B. |
Drug-coated stents and methods of use therefor
|
US7166692B2
(en)
|
2003-03-04 |
2007-01-23 |
Canbrex Bio Science Walkersville, Inc. |
Intracellular delivery of small molecules, proteins, and nucleic acids
|
EP2295433A3
(en)
|
2003-03-06 |
2011-07-06 |
Eisai R&D Management Co., Ltd. |
JNK inhibitors
|
WO2004092339A2
(en)
|
2003-04-11 |
2004-10-28 |
Ilex Products, Inc. |
Modulation of muc1 mediated signal transduction
|
ATE479763T1
(de)
|
2003-04-29 |
2010-09-15 |
Avi Biopharma Inc |
Zusammensetzungen zur verbesserung der antisense- wirksamkeit und des transports von nukleinsäureanalog in zellen
|
CA2529752A1
(en)
|
2003-06-20 |
2005-09-15 |
The Regents Of The University Of California |
Polypeptide transduction and fusogenic peptides
|
US20050048995A1
(en)
|
2003-08-25 |
2005-03-03 |
Motorola, Inc. |
System and method for controlling the operating characteristics of a buffer
|
KR100685345B1
(ko)
|
2004-03-27 |
2007-02-22 |
학교법인조선대학교 |
세포사 유도 펩타이드
|
KR20060134198A
(ko)
|
2004-04-08 |
2006-12-27 |
어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. |
Jnk 저해제 및 시클로스포린을 포함하는 조성물
|
CA2578122A1
(en)
|
2004-08-27 |
2006-03-02 |
Gpc Biotech Ag |
Pyrimidine derivatives
|
US20060094753A1
(en)
|
2004-10-29 |
2006-05-04 |
Alcon, Inc. |
Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
|
EP1656951A1
(en)
|
2004-11-12 |
2006-05-17 |
Xigen S.A. |
Conjugates with enhanced cell uptake activity
|
US20100256041A1
(en)
|
2004-11-12 |
2010-10-07 |
Christophe Bonny |
Conjugate Molecule Compounds With Enhanced Cell Uptake Activity
|
EP1661912A1
(en)
|
2004-11-29 |
2006-05-31 |
Xigen S.A. |
Fusion protein comprising a BH3-domain of a BH3-only protein
|
EP1676574A3
(en)
|
2004-12-30 |
2006-07-26 |
Johnson & Johnson Vision Care, Inc. |
Methods for promoting survival of transplanted tissues and cells
|
US20060223807A1
(en)
|
2005-03-29 |
2006-10-05 |
University Of Massachusetts Medical School, A Massachusetts Corporation |
Therapeutic methods for type I diabetes
|
AU2006252938A1
(en)
|
2005-04-29 |
2006-12-07 |
Celgene Corporation |
Solid forms of 1-( 5-(IH-I , 2 , 4 -triazol- 5 -yl)(1H-indazol-3-yl))-3-(2-piperidylethoxy)benzene
|
US20070015779A1
(en)
|
2005-04-29 |
2007-01-18 |
John Griffin |
Compositions and treatments for inhibiting kinase and/or hmg-coa reductase
|
US20070003531A1
(en)
|
2005-06-30 |
2007-01-04 |
University Of Connecticut |
Methods for improving immunotherapy by enhancing survival of antigen-specific cytotoxic T lymphocytes
|
US8080517B2
(en)
|
2005-09-12 |
2011-12-20 |
Xigen Sa |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
WO2007031098A1
(en)
|
2005-09-12 |
2007-03-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
|
US10045953B2
(en)
|
2006-07-06 |
2018-08-14 |
Case Western Reserve University |
Ceramide composition and method of use
|
EP1884521A1
(en)
|
2006-07-31 |
2008-02-06 |
Xigen S.A. |
Fusion peptide for inhibiting interaction of neuronal NMDA receptor (NMDAR) and NMDAR interacting proteins
|
US20080051410A1
(en)
|
2006-08-02 |
2008-02-28 |
Northwestern University |
Protein Kinase Targeted Therapeutics
|
ATE543498T1
(de)
|
2006-09-08 |
2012-02-15 |
Hoffmann La Roche |
Benzotriazol kinasemodulatoren
|
CA2663545A1
(en)
|
2006-09-19 |
2008-03-27 |
Phylogica Limited |
Neuroprotective peptide inhibitors of ap-1 signaling and uses thereof
|
GB0702259D0
(en)
|
2007-02-06 |
2007-03-14 |
Eisai London Res Lab Ltd |
7-azaindole derivatives
|
AU2008337100B2
(en)
|
2007-12-17 |
2013-02-28 |
Pfizer Limited |
Treatment of interstitial cystitis
|
MX2010009157A
(es)
|
2008-02-25 |
2010-09-24 |
Eyegate Pharma S A S |
Suministro mejorado de un agente terapeutico para tejidos oculares a traves de iontoforesis.
|
CN102065897B
(zh)
|
2008-04-29 |
2013-11-13 |
法奈科斯公司 |
基于磺胺异噁唑的组合物用于制备治疗阿茨海默病的药物的应用
|
ES2530723T3
(es)
|
2008-05-07 |
2015-03-04 |
Univ California |
Reposición y enriquecimiento terapéuticos de la lubricación de la superficie ocular
|
WO2009143864A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
|
WO2009143865A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
US20100183633A1
(en)
*
|
2008-12-04 |
2010-07-22 |
University Of Massachusetts |
Interleukin 6 and tumor necrosis factor alpha as biomarkers of jnk inhibition
|
WO2010072228A1
(en)
|
2008-12-22 |
2010-07-01 |
Xigen S.A. |
Novel transporter constructs and transporter cargo conjugate molecules
|
WO2010073104A2
(en)
|
2008-12-23 |
2010-07-01 |
Carmel - Haifa University Economic Corp Ltd. |
Improving cognitive function
|
SG10201407409WA
(en)
|
2009-02-06 |
2015-01-29 |
Elan Pharm Inc |
Inhibitors of jun n-terminal kinase
|
EA201171188A1
(ru)
*
|
2009-03-30 |
2012-05-30 |
Сантен Фармасьютикал Ко., Лтд. |
Профилактическое или терапевтическое средство против болезни сетчатки и способ профилактики или лечения болезни сетчатки с использованием jnk (c-jun-аминоконцевая киназа)-ингибиторного пептида, а также применение указанного пептида
|
CN102573855A
(zh)
|
2009-10-22 |
2012-07-11 |
霍夫曼-拉罗奇有限公司 |
轴突变性的调节
|
EP2519249A4
(en)
|
2009-12-31 |
2013-06-26 |
Stealth Peptides Int Inc |
METHODS OF REALIZING AORTO-CORONARY BRIDGE
|
WO2011160653A1
(en)
|
2010-06-21 |
2011-12-29 |
Xigen S.A. |
Novel jnk inhibitor molecules
|
JP5857056B2
(ja)
|
2010-10-14 |
2016-02-10 |
ザイジェン インフラメーション エルティーディー |
慢性又は非慢性の炎症性眼疾患を治療するためのjnkシグナル伝達経路の細胞透過性ペプチド阻害剤の使用
|
DK2627346T3
(en)
|
2010-10-14 |
2016-06-13 |
Xigen Inflammation Ltd |
Cell permeable peptide inhibitors of the JNK signal transduction pathway for use in the treatment of uveitis
|
US8471027B2
(en)
|
2011-04-06 |
2013-06-25 |
Hoffmann-La Roche Inc. |
Adamantyl compounds
|
WO2013079213A1
(en)
|
2011-11-30 |
2013-06-06 |
Xigen Inflammation Ltd. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of dry eye syndrome
|
WO2013091670A1
(en)
*
|
2011-12-21 |
2013-06-27 |
Xigen S.A. |
Novel jnk inhibitor molecules for treatment of various diseases
|
JP6317548B2
(ja)
|
2013-04-10 |
2018-04-25 |
キヤノン株式会社 |
撮像装置及びその制御方法
|
WO2014206427A1
(en)
|
2013-06-26 |
2014-12-31 |
Xigen Inflammation Ltd. |
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
WO2015197193A2
(en)
|
2014-06-26 |
2015-12-30 |
Xigen Inflammation Ltd. |
New use for jnk inhibitor molecules for treatment of various diseases
|
JP2016523274A
(ja)
|
2013-06-26 |
2016-08-08 |
ザイジェン インフラメーション リミテッド |
種々の疾患を処置するためのjnkシグナル伝達経路の新規の細胞透過性ペプチド阻害剤の使用
|
WO2014206426A1
(en)
|
2013-06-26 |
2014-12-31 |
Xigen Inflammation Ltd. |
New use for jnk inhibitor molecules for treatment of various diseases
|
JP2015197193A
(ja)
|
2014-04-02 |
2015-11-09 |
トヨタ自動車株式会社 |
車両用無段変速機の油圧制御装置
|
US10029012B2
(en)
|
2014-09-05 |
2018-07-24 |
University Of Pittsuburgh—Of The Commonwealth System Of Higher Education |
Peptide-mediated intravesical delivery of therapeutic and diagnostic agents
|
CN107969126A
(zh)
|
2015-06-26 |
2018-04-27 |
埃克西金炎症有限公司 |
Jnk信号转导通路的细胞穿透肽抑制剂用于治疗轻度认知损害的新用途
|